Onconetix (ONCO) Payables (2021 - 2026)
Onconetix (ONCO) posted quarterly Payables of $2.5 million for Q1 2026, down 78.42% year-over-year from $11.5 million in Q1 2025, and down 71.52% quarter-over-quarter from $8.7 million in Q4 2025.
Onconetix (ONCO) Payables (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Payables for 6 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 78.42% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (down 78.42% YoY), while the FY2025 annual figure was $8.7 million, down 33.34% from the prior year.
- Payables retreated to $2.5 million in Q1 2026 per ONCO's latest filing, from $8.7 million in the prior quarter.
- Across five years, Payables topped out at $14.9 million in Q4 2023 and bottomed at $876364.0 in Q3 2022.
- Historically, Payables has averaged $7.0 million across 5 years, with a median of $8.7 million in 2025.
- Annual changes were most pronounced in 2023 — Payables surged 1476.98% — and 2024, when it plunged 89.7%.
- Onconetix's Payables stood at $1.5 million in 2022, then jumped by 885.48% to $14.9 million in 2023, then declined by 12.06% to $13.1 million in 2024, then sank by 33.34% to $8.7 million in 2025, then slumped by 71.52% to $2.5 million in 2026.
- Business Quant data shows ONCO's Payables at $2.5 million in Q1 2026, $8.7 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 2.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 8.74 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 11.31 Mn |
| Mar 31, 2025 | 11.54 Mn |
| Dec 31, 2024 | 13.12 Mn |
| Sep 30, 2024 | 10.94 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 11.91 Mn |
| Dec 31, 2023 | 14.91 Mn |
| Sep 30, 2023 | 13.82 Mn |
| Jun 30, 2023 | 10.70 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 876,364.00 |
| Jun 30, 2022 | 978,344.00 |
| Mar 31, 2022 | 907,538.00 |
| Dec 31, 2021 | 582,605.00 |